ARTICLE | Company News
BioNTech gets rights to modified mRNA patents from Cellscript
October 20, 2017 6:09 PM UTC
In September, cancer immunotherapy company BioNTech AG (Mainz, Germany) said it received non-exclusive rights from Cellscript LLC (Madison, Wis.) to patents covering nucleoside-modified mRNA for use in all in vivo applications, including therapeutic and non-therapeutic applications in humans and animals. ...
BCIQ Company Profiles